Chemically Assisted Capsulectomy-A New Clinical Approach

Implant Capsular Contracture Clinical Trial

Official title: Chemically Assisted Capsulectomy-A New Clinical Approach

Status Terminated

Clinical Trial Summary

The purpose of this study is to make available an agent,Mesna, which can assist the surgeon during the procedure of capsulectomy.

Clinical Trial Description

Mesna is a FDA approved drug for the treatment of respiratory diseases and is used a protective agent against drugs in oncology patients. It has also been used in Gynecologic surgery and ENT. Mesna is a drug that breaks down adhesions between tissue layers. ;

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Contracture
• Implant Capsular Contracture

• NCT number: NCT00758667
• Study type: Interventional
• Source: Vanderbilt University
• Status: Terminated
• Phase: N/A
• Start date: January 2005
• Completion date: December 2009